Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator-blinded, Controlled Study to Evaluate the Safety and Clinical Performance of OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

NCT04960722 is registered in ClinicalTrials.gov with BioGend Therapeutics Co.Ltd as lead sponsor.

NCT NCT04960722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04960722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator-blinded, Controlled Study to Evaluate the Safety and Clinical Performance of OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting
Lead sponsor
BioGend Therapeutics Co.Ltd
Phase
Not applicable
Overall status
Completed
Start date
January 11, 2022
Completion date
February 25, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tibia fracture